Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach

Cancer immunotherapy moderates the immune system’s ability to fight cancer. Due to its extreme complexity, scientists are working to put together all the puzzle pieces to get a clearer picture of the immune system. Shreds of available evidence show the connection between cancer and the immune system...

Full description

Bibliographic Details
Main Authors: Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Arunraj Namachivayam, Reshma Murali, D. S. Prabakaran, Raja Ganesan, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Gnanasambandan Ramanathan, George Priya Doss C., Abilash Valsala Gopalakrishnan
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/9/1493
_version_ 1797481563275919360
author Anirban Goutam Mukherjee
Uddesh Ramesh Wanjari
Arunraj Namachivayam
Reshma Murali
D. S. Prabakaran
Raja Ganesan
Kaviyarasi Renu
Abhijit Dey
Balachandar Vellingiri
Gnanasambandan Ramanathan
George Priya Doss C.
Abilash Valsala Gopalakrishnan
author_facet Anirban Goutam Mukherjee
Uddesh Ramesh Wanjari
Arunraj Namachivayam
Reshma Murali
D. S. Prabakaran
Raja Ganesan
Kaviyarasi Renu
Abhijit Dey
Balachandar Vellingiri
Gnanasambandan Ramanathan
George Priya Doss C.
Abilash Valsala Gopalakrishnan
author_sort Anirban Goutam Mukherjee
collection DOAJ
description Cancer immunotherapy moderates the immune system’s ability to fight cancer. Due to its extreme complexity, scientists are working to put together all the puzzle pieces to get a clearer picture of the immune system. Shreds of available evidence show the connection between cancer and the immune system. Immune responses to tumors and lymphoid malignancies are influenced by B cells, γδT cells, NK cells, and dendritic cells (DCs). Cancer immunotherapy, which encompasses adoptive cancer therapy, monoclonal antibodies (mAbs), immune checkpoint therapy, and CART cells, has revolutionized contemporary cancer treatment. This article reviews recent developments in immune cell regulation and cancer immunotherapy. Various options are available to treat many diseases, particularly cancer, due to the progress in various immunotherapies, such as monoclonal antibodies, recombinant proteins, vaccinations (both preventative and curative), cellular immunotherapies, and cytokines.
first_indexed 2024-03-09T22:16:24Z
format Article
id doaj.art-8b191c8a52bc4c7d918b3f2cf6b4ab19
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T22:16:24Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-8b191c8a52bc4c7d918b3f2cf6b4ab192023-11-23T19:22:04ZengMDPI AGVaccines2076-393X2022-09-01109149310.3390/vaccines10091493Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic ApproachAnirban Goutam Mukherjee0Uddesh Ramesh Wanjari1Arunraj Namachivayam2Reshma Murali3D. S. Prabakaran4Raja Ganesan5Kaviyarasi Renu6Abhijit Dey7Balachandar Vellingiri8Gnanasambandan Ramanathan9George Priya Doss C.10Abilash Valsala Gopalakrishnan11Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, Tamil Nadu, IndiaDepartment of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, Tamil Nadu, IndiaDepartment of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, Tamil Nadu, IndiaDepartment of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, Tamil Nadu, IndiaDepartment of Radiation Oncology, College of Medicine, Chungbuk National University, Chungdae-ro 1, Seowon-gu, Cheongju 28644, KoreaInstitute for Liver and Digestive Diseases, Hallym University, Chuncheon 24252, KoreaCentre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College & Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, Tamil Nadu, IndiaDepartment of Life Sciences, Presidency University, Kolkata 700073, West Bengal, IndiaHuman Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641046, Tamil Nadu, IndiaDepartment of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, Tamil Nadu, IndiaDepartment of Integrative Biology, School of Bio Sciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, Tamil Nadu, IndiaDepartment of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, Tamil Nadu, IndiaCancer immunotherapy moderates the immune system’s ability to fight cancer. Due to its extreme complexity, scientists are working to put together all the puzzle pieces to get a clearer picture of the immune system. Shreds of available evidence show the connection between cancer and the immune system. Immune responses to tumors and lymphoid malignancies are influenced by B cells, γδT cells, NK cells, and dendritic cells (DCs). Cancer immunotherapy, which encompasses adoptive cancer therapy, monoclonal antibodies (mAbs), immune checkpoint therapy, and CART cells, has revolutionized contemporary cancer treatment. This article reviews recent developments in immune cell regulation and cancer immunotherapy. Various options are available to treat many diseases, particularly cancer, due to the progress in various immunotherapies, such as monoclonal antibodies, recombinant proteins, vaccinations (both preventative and curative), cellular immunotherapies, and cytokines.https://www.mdpi.com/2076-393X/10/9/1493cancerimmune cellscheckpointsCART cellmonoclonal Absimmunotherapy
spellingShingle Anirban Goutam Mukherjee
Uddesh Ramesh Wanjari
Arunraj Namachivayam
Reshma Murali
D. S. Prabakaran
Raja Ganesan
Kaviyarasi Renu
Abhijit Dey
Balachandar Vellingiri
Gnanasambandan Ramanathan
George Priya Doss C.
Abilash Valsala Gopalakrishnan
Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach
Vaccines
cancer
immune cells
checkpoints
CART cell
monoclonal Abs
immunotherapy
title Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach
title_full Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach
title_fullStr Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach
title_full_unstemmed Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach
title_short Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach
title_sort role of immune cells and receptors in cancer treatment an immunotherapeutic approach
topic cancer
immune cells
checkpoints
CART cell
monoclonal Abs
immunotherapy
url https://www.mdpi.com/2076-393X/10/9/1493
work_keys_str_mv AT anirbangoutammukherjee roleofimmunecellsandreceptorsincancertreatmentanimmunotherapeuticapproach
AT uddeshrameshwanjari roleofimmunecellsandreceptorsincancertreatmentanimmunotherapeuticapproach
AT arunrajnamachivayam roleofimmunecellsandreceptorsincancertreatmentanimmunotherapeuticapproach
AT reshmamurali roleofimmunecellsandreceptorsincancertreatmentanimmunotherapeuticapproach
AT dsprabakaran roleofimmunecellsandreceptorsincancertreatmentanimmunotherapeuticapproach
AT rajaganesan roleofimmunecellsandreceptorsincancertreatmentanimmunotherapeuticapproach
AT kaviyarasirenu roleofimmunecellsandreceptorsincancertreatmentanimmunotherapeuticapproach
AT abhijitdey roleofimmunecellsandreceptorsincancertreatmentanimmunotherapeuticapproach
AT balachandarvellingiri roleofimmunecellsandreceptorsincancertreatmentanimmunotherapeuticapproach
AT gnanasambandanramanathan roleofimmunecellsandreceptorsincancertreatmentanimmunotherapeuticapproach
AT georgepriyadossc roleofimmunecellsandreceptorsincancertreatmentanimmunotherapeuticapproach
AT abilashvalsalagopalakrishnan roleofimmunecellsandreceptorsincancertreatmentanimmunotherapeuticapproach